Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts.

about

Antisense PMO cocktails effectively skip dystrophin exons 45-55 in myotubes transdifferentiated from DMD patient fibroblasts.

Item

http://www.wikidata.org/entity/Q55284165

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Antisense PMO cocktails effect ...... from DMD patient fibroblasts.

@en

Antisense PMO cocktails effect ...... from DMD patient fibroblasts.

@nl

type

Item

label

Antisense PMO cocktails effect ...... from DMD patient fibroblasts.

@en

Antisense PMO cocktails effect ...... from DMD patient fibroblasts.

@nl

prefLabel

Antisense PMO cocktails effect ...... from DMD patient fibroblasts.

@en

Antisense PMO cocktails effect ...... from DMD patient fibroblasts.

@nl

P1476

Antisense PMO cocktails effect ...... d from DMD patient fibroblasts

@en

P2093

Joshua Lee

http://www.w3.org/2001/XMLSchema#string

Shin'ichi Takeda

http://www.w3.org/2001/XMLSchema#string

Takashi Saito

http://www.w3.org/2001/XMLSchema#string

Yoshitsugu Aoki

http://www.w3.org/2001/XMLSchema#string

P2860

Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy

A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground

Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy.

Optimizing exon skipping therapies for DMD.

A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy.

Safety and pharmacokinetic profiles of phosphorodiamidate morpholino oligomers with activity against ebola virus and marburg virus: results of two single-ascending-dose studies.

Antisense therapy in neurology

One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice.

P304

e0197084

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0197084

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William Duddy

Yusuke Echigoya

Toshifumi Yokota

P577

2018-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29771942

http://www.w3.org/2001/XMLSchema#string

P932

5957359

http://www.w3.org/2001/XMLSchema#string